Pharmaceuticals

Antibody Purification Services Market Size, Share & Trends Analysis Report By Antibody Types (Monoclonal, and Polyclonal), By Purification Methods, By End-Users, Region And Segment Forecasts, 2025-2034

Antibody Purification Services Market is expected to grow at an 10.5% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Effective and targeted therapies are becoming more and more necessary due to the rising incidence of infectious and chronic illnesses. Pharmaceutical and biotechnology businesses are outsourcing antibody manufacturing and purification services more frequently in an e...

Report ID: 1248  |  

Delivery: Immediate  |  

Published: June 2025   |  

No. of Pages: 180

Implantable Hormone Pellets Market Size, Share & Trends Analysis By Type (Progesterone Pellets, Estradiol (Estrogen) Pellets, Testosterone Pellets), By Application (Female, Male), by Region, And by Segment Forecasts, 2025-2034.

Implantable Hormone Pellets Market Size is valued at USD 0.20 Bn in 2024 and is predicted to reach USD 0.37 Bn by the year 2034 at a 6.3% CAGR during the forecast period for 2025-2034. Implantable hormone pellets are small, bioidentical hormone implants (e.g., estradiol, testosterone) inserted under the skin for hormone replacement therapy, lasting 3–6 months. They treat menopause, hypogonadism, or support gender-affirming care, offering...

Report ID: 3098  |  

Delivery: Immediate  |  

Published: June 2025   |  

No. of Pages: 180

mRNA Post-Transcriptional Enzymatic Capping Market Share & Trends Analysis Report, By Product Type (Capping Enzymes, Capping Kits, Reagents and Consumables, Custom mRNA Synthesis Services), By Application (mRNA Vaccines, mRNA Therapeutics, Research Tools, Emerging Applications), By End-User, By Region, and Segment Forecasts, 2025-2034

Global mRNA Post-Transcriptional Enzymatic Capping Market Size is predicted to develop a 6.8% CAGR during the forecast period from 2025 to 2034. The process of adding a 5′ cap structure to messenger RNA (mRNA) via in vitro transcription (IVT) using enzymes such as RNA triphosphatase, guanylyltransferase, and methyltransferases is known as mRNA post-transcriptional enzymatic capping. The market encompasses post-transcriptional enzymati...

Report ID: 3104  |  

Delivery: Immediate  |  

Published: June 2025   |  

No. of Pages: 170

Tag-Assisted Peptide Synthesis (TAPS) Services Market Share & Trends Analysis Report, By Technology (Chemical Synthesis with Tags, Hybrid Synthesis, C-Terminal Amidation Synthesis), By Application (Therapeutics, Drug Discovery, Research), By End-User, By Region, and Segment Forecasts, 2025-2034

Global Tag-Assisted Peptide Synthesis (TAPS) Services Market Size is predicted to grow at a 9.2 % CAGR during the forecast period for 2025-2034. Tag-Assisted Peptide Synthesis (TAPS) services involve specialized methods for synthesizing peptides using chemical or molecular tags to enhance efficiency, solubility, and purification throughout the synthesis process. These services, offered by companies and research laboratories, support applications...

Report ID: 3107  |  

Delivery: Immediate  |  

Published: June 2025   |  

No. of Pages: 160

mRNA 2.0 Market Share & Trends Analysis Report, By Technology (Self-Amplifying mRNA (saRNA), Optimized Non-Amplifying mRNA, Circular RNA (circRNA), Programmable/Logic-Gated mRNA), By Application (Infectious Disease Vaccines, Oncology, Rare & Genetic Diseases, Autoimmune & Inflammatory Diseases, Cardiovascular & Metabolic), By End-User, By Region, and Segment Forecasts, 2025-2034

mRNA 2.0 market Size is predicted to grow at a 12.8% CAGR during the forecast period for 2025-2034.  “mRNA?2.0” refers to the next-generation versions of mRNA therapies and vaccines engineered to be more potent, dose-efficient, stable, and adaptable than first-generation mRNA platforms. These advanced systems incorporate amplification mechanisms such as self-amplifying RNA (saRNA) and trans-amplifying RNA (taRNA), enabling str...

Report ID: 3111  |  

Delivery: Immediate  |  

Published: June 2025   |  

No. of Pages: 180

CD Targeted Bispecific Antibody Market Size, Share & Trends Analysis Report By Target Type (CD3, CD19 and CD30/CD16A), Region And Segment Forecasts, 2025-2034.

CD Targeted Bispecific Antibody Market is expected at an 14.5% CAGR during the forecast period for 2025-2034. InsightAce Analytic’s “Global CD Targeted Bispecific Antibody Market Research Report 2023” is a comprehensive analysis, forecast, market dynamics and major trends report covering key market data on the CD Targeted Bispecific Antibody target type segments. This market research report provides market estimation and fore...

Report ID: 1144  |  

Delivery: Immediate  |  

Published: June 2025   |  

No. of Pages: 160

Peptide Cancer Vaccine Market Size, Share & Trends Analysis By Type (Multivalent Peptide Vaccine, Personalized Peptide Vaccine, Peptide Cocktail Type, Hybrid Peptide Vaccine, Peptide-Pulsed Dendritic Cancer Vaccine), By Application (Breast Cancer, Prostate Cancer, Lung Cancer, Melanoma), by Region, And by Segment Forecasts, 2025-2034.

Peptide Cancer Vaccine Market Size is valued at USD 1.6 Bn in 2024 and is predicted to reach USD 13.9 Bn by the year 2034 at a 24.5% CAGR during the forecast period for 2025-2034. Peptide cancer vaccines utilize tumour-derived peptides that stimulate T-cell immune responses against cancer, focusing on antigens such as tumour-associated antigens (TAAs) or neoantigens. They are secure, targeted, and economically viable, yet encounter obstacles s...

Report ID: 3100  |  

Delivery: Immediate  |  

Published: June 2025   |  

No. of Pages: 179

RNAi Drug Delivery Market Size, Share & Trends Analysis By Target Disease ( Cancer, Metabolic Diseases, Genetic Disorders, Viral Infections, Others), By Technology (miRNA, siRNA, shRNA, Others), By Targeted Tissue (Heart, Brain, Liver, Lungs, Others), By Delivery System (Nanoparticle Drug Delivery Technology, Aptamer Drug Delivery Technology, Pulmonary Drug Delivery Technology, Nucleic Acid Drug Delivery Technology), By Route of Administration (Oral, Intramuscular, Intravenous, Local Injection, Subcutaneous), By End-User), by Region, And by Segment Forecasts, 2025-2034

RNAi Drug Delivery Market Size is valued at USD 108.8 Bn in 2024 and is predicted to reach USD 559.6 Bn by the year 2034 at a 18.1% CAGR during the forecast period for 2025-2034. Drug delivery using RNA interference (RNAi) holds promise for the creation of new treatments, especially in the field of gene expression modification. This strategy uses RNA interference (RNAi), a natural mechanism, to silence particular genes, potentially providing t...

Report ID: 3095  |  

Delivery: Immediate  |  

Published: June 2025   |  

No. of Pages: 179

Aseptic Fill Finish Market Size, Share & Trends Analysis Report By Type of Molecule (Branded (Biologics, Small Molecules), Generic (Biosimilars, Small Molecules), Product Type (Ampoules, Cartridges, Prefilled Syringes, Vials and Others), Type of Drug Product (Antibodies, Cell Therapies, Gene Therapies, Oligonucleotides, Recombinant Proteins, Vaccines and Other Products), Scale of Operation (Preclinical / Clinical and Commercial), Company Size, Region, And Segment Forecasts, 2025-2034

Global Aseptic Fill Finish Market Size is valued at USD 6.0 Billion in 2024 and is predicted to reach USD 16.9 Billion by the year 2034 at a 11.0% CAGR during the forecast period for 2025-2034. Aseptic processing is an important step in drug manufacturing as it involves aseptically filling and packaging medicinal products into containers. The risk of microbial contamination is very high in aseptic filling. Therefore, the aseptic filling s...

Report ID: 1880  |  

Delivery: Immediate  |  

Published: June 2025   |  

No. of Pages: 180

Infliximab Biosimilar Market Size, Share & Trends Analysis Report By Brand, Applications (Crohn’s disease, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, ankylosing spondylitis, plaque psoriasis, and others), Distribution Channel, Region And Segment Forecasts, 2025-2034

Infliximab Biosimilar Market Size is valued at XX Million in 2024 and is predicted to reach XX Million by the year 2034 at an XX % CAGR during the forecast period for 2025-2034. Infliximab is chimeric anti-TNF monoclonal antibody approved for the treatment of Chron’s Disease. It is also approved for the treatment of other autoimmune diseases such as Psoriasis, rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and others. It is...

Report ID: 1060  |  

Delivery: Immediate  |  

Published: June 2025   |  

No. of Pages: 180